Citation: Dg. Fujikawa et al., NEURONAL DEATH INDUCED BY LITHIUM-PILOCARPINE-INDUCED SEIZURES IS MORPHOLOGICALLY NECROTIC DESPITE APOPTOTIC BIOCHEMICAL FEATURES, Annals of neurology, 44(3), 1998, pp. 87-87
Citation: K. Swarztrauber et Dg. Fujikawa, AN ELECTROENCEPHALOGRAPHIC STUDY COMPARING MAXIMUM BLINK RATES IN SCHIZOPHRENIC AND NONSCHIZOPHRENIC PSYCHIATRIC-PATIENTS AND NONPSYCHIATRIC CONTROL SUBJECTS, Biological psychiatry, 43(4), 1998, pp. 282-287
Citation: Dg. Fujikawa, EFFECTS OF N-METHYL-D-ASPARTATE-RECEPTOR BLOCKADE ON HIGH-POTASSIUM-INDUCED NEURONAL DEATH AND GLUTAMATE RELEASE, Neuroscience letters, 226(1), 1997, pp. 25-28
Citation: Dg. Fujikawa et al., EFFECTS OF SODIUM-CHANNEL AND GLUTAMATE-RECEPTOR BLOCKADE ON HIGH-POTASSIUM-INDUCED ELEVATION OF EXTRACELLULAR GLUTAMATE AND NEURONAL DEATHIN-VIVO, Journal of neurochemistry, 69, 1997, pp. 214-214
Authors:
FUJIKAWA DG
KIM JS
DANIELS AH
ALCARAZ AF
SOHN TB
Citation: Dg. Fujikawa et al., IN-VIVO ELEVATION OF EXTRACELLULAR POTASSIUM IN THE RAT AMYGDALA INCREASES EXTRACELLULAR GLUTAMATE AND ASPARTATE AND DAMAGES NEURONS, Neuroscience, 74(3), 1996, pp. 695-706
Citation: Dg. Fujikawa et Tb. Sohn, THE COMPETITIVE N-METHYL-D-ASPARTATE RECEPTOR ANTAGONIST CGP-40116 PROTECTS AGAINST HIGH POTASSIUM-INDUCED NEURONAL CELL-DEATH IN-VIVO, Neurology, 46(2), 1996, pp. 3127-3127
Citation: Dg. Fujikawa et al., IS THE PROTECTIVE EFFECT OF THE COMPETITIVE NMDA-RECEPTOR ANTAGONIST CGP-40116 AGAINST HIGH-POTASSIUM-INDUCED NEURONAL CELL-DEATH ASSOCIATED WITH REDUCTIONS IN INCREASED EXTRACELLULAR GLUTAMATE AND ASPARTATE CONCENTRATIONS, Journal of neurochemistry, 66, 1996, pp. 82-82
Citation: Dg. Fujikawa et Rh. Jacobsen, CHRONICALLY-IMPAIRED FRONTAL-LOBE FUNCTION FROM SUBCLINICAL ELECTROGRAPHIC SEIZURES, Epilepsia, 36, 1995, pp. 563-563
Citation: Dg. Fujikawa et al., THE COMPETITIVE NMDA RECEPTOR ANTAGONIST CGP-40116 PROTECTS AGAINST STATUS EPILEPTICUS-INDUCED NEURONAL DAMAGE, Epilepsy research, 17(3), 1994, pp. 207-219
Citation: Dg. Fujikawa et al., THE NEUROPROTECTIVE EFFICACY OF THE COMPETITIVE NMDA-RECEPTOR ANTAGONIST CGP-40116 WHEN GIVEN BEFORE AND AFTER THE ONSET OF LIMBIC STATUS EPILEPTICUS, Neurology, 43(4), 1993, pp. 303-303